Skip to main content
Erschienen in: Supportive Care in Cancer 12/2021

18.06.2021 | Original Article

“There’s somebody like me”: perspectives of a peer-to-peer gynecologic cancer mentorship program

verfasst von: Hannah Kang Moran, Joanna Veazey Brooks, Lori Spoozak

Erschienen in: Supportive Care in Cancer | Ausgabe 12/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The Ovarian Cancer Research Alliance’s Woman to Woman (W2W) program is a peer mentorship program for women with gynecological cancer that was founded in 2004 and has expanded to 43 sites nationwide. An initial program survey was conducted in 2013, but no qualitative studies have investigated patient experiences with peer support programs for gynecologic cancer in the USA. This study examines the match experience at one program site. The aim of this qualitative study was to capture mentor and mentee experiences giving and receiving peer support, including how relationships were initiated and developed.

Methods

Hour-long, semi-structured interviews were conducted with both mentors and mentees. Interviews focused on the dynamics of the mentor–mentee relationship. Interviews were recorded, transcribed verbatim, and open-coded. A qualitative descriptive approach was used to organize findings into themes.

Results

Sixteen participants (N = 16) were interviewed (seven mentors and nine mentees.) Three broad themes emerged: (i) pathways to the program; (ii) how connection occurred; and (iii) themes of compatibility. While program participants universally valued their match experience, frequency and mode of communication, as well as expectations of the match relationship were widely divergent among the program participants.

Conclusion

The W2W peer mentorship program is a valuable resource for patients with gynecologic cancer. Refining the wants and needs of mentees including mode of communication, frequency of communication, type of support desired, identifying topics of mutual interest, and introducing the concept of recurrence may improve the connectivity experienced by mentor–mentee dyads.
Literatur
3.
8.
Zurück zum Zitat Louisa M, Hoey SCI, White VM, Jefford M (2007) Systematic review of peer-support programs for people with cancer. Patient Educ Couns 70(3):315–337 Louisa M, Hoey SCI, White VM, Jefford M (2007) Systematic review of peer-support programs for people with cancer. Patient Educ Couns 70(3):315–337
13.
17.
Zurück zum Zitat Huntingdon B, Schofield P, Wolfowicz Z, Bergin R, Kabel D, Edmunds J, Penberthy S, Juraskova I (2016) Toward structured peer support interventions in oncology: a qualitative insight into the experiences of gynaecological cancer survivors providing peer support. Support Care Cancer 24(2):849–856. https://doi.org/10.1007/s00520-015-2853-zCrossRefPubMed Huntingdon B, Schofield P, Wolfowicz Z, Bergin R, Kabel D, Edmunds J, Penberthy S, Juraskova I (2016) Toward structured peer support interventions in oncology: a qualitative insight into the experiences of gynaecological cancer survivors providing peer support. Support Care Cancer 24(2):849–856. https://​doi.​org/​10.​1007/​s00520-015-2853-zCrossRefPubMed
Metadaten
Titel
“There’s somebody like me”: perspectives of a peer-to-peer gynecologic cancer mentorship program
verfasst von
Hannah Kang Moran
Joanna Veazey Brooks
Lori Spoozak
Publikationsdatum
18.06.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 12/2021
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-021-06348-w

Weitere Artikel der Ausgabe 12/2021

Supportive Care in Cancer 12/2021 Zur Ausgabe

Mehr Brustkrebs, aber weniger andere gynäkologische Tumoren mit Levonorgestrel-IUS

04.06.2024 Levonorgestrel Nachrichten

Unter Frauen, die ein Levonorgestrel-freisetzendes intrauterines System (IUS) verwenden, ist die Brustkrebsrate um 13% erhöht. Dafür kommt es deutlich seltener zu Endometrium-, Zervix- und Ovarialkarzinomen.

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Antikörper mobilisiert Neutrophile gegen Krebs

03.06.2024 Onkologische Immuntherapie Nachrichten

Ein bispezifischer Antikörper formiert gezielt eine Armee neutrophiler Granulozyten gegen Krebszellen. An den Antikörper gekoppeltes TNF-alpha soll die Zellen zudem tief in solide Tumoren hineinführen.

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.